Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 1.48%.

  • Verrica Pharmaceuticals' Return on Capital Employed rose 21400.0% to 1.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.48%, marking a year-over-year increase of 21400.0%. This contributed to the annual value of 1.7% for FY2024, which is 2700.0% down from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Return on Capital Employed stood at 1.48% for Q3 2025, which was up 21400.0% from 3.39% recorded in Q2 2025.
  • Verrica Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.39% for Q1 2023, and its period low was 4.54% during Q4 2024.
  • Its 5-year average for Return on Capital Employed is 1.66%, with a median of 1.33% in 2022.
  • As far as peak fluctuations go, Verrica Pharmaceuticals' Return on Capital Employed tumbled by -36300bps in 2024, and later surged by 21400bps in 2025.
  • Verrica Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.81% in 2021, then surged by 39bps to 0.49% in 2022, then tumbled by -86bps to 0.91% in 2023, then plummeted by -400bps to 4.54% in 2024, then skyrocketed by 67bps to 1.48% in 2025.
  • Its last three reported values are 1.48% in Q3 2025, 3.39% for Q2 2025, and 2.96% during Q1 2025.